Patients, Pipeline, and Promise: Software-Enhanced Drugs
On-Demand Webinar
Gain valuable insights from a panel of experts, including Anthony Costello, Medidata’s CEO, and David Klein, Click Therapeutics Founder and CEO, as they discuss the opportunities that Software-Enhanced (SE) drugs present for forward-thinking pharmaceutical companies, and why now is the time to embrace them.
Key Learnings:
- Digital therapeutics and Software-Enhanced (SE) drugs defined
- Potential benefits for Commercial and R&D teams
- How specific therapeutic areas like Oncology and Cardiometabolics can leverage SE drugs to significantly improve care
- How you can become an expert on a topic poised to redefine patient care
- How Click’s expertise in Software-Enhanced drugs, Medidata’s leading position in clinical trial technology and the combined partnership can help you innovate and boost your pipeline